B-Disease	0	5	Coats
I-Disease	5	6	'
I-Disease	7	14	disease
O	15	24	diagnosed
O	25	27	in
B-Characteristic	28	37	adulthood
O	37	38	.

O	40	42	To
O	43	54	investigate
O	55	58	the
O	59	73	manifestations
O	74	77	and
O	78	86	clinical
O	87	93	course
O	94	96	of
B-Disease	97	102	Coats
I-Disease	102	103	'
I-Disease	104	111	disease
O	112	121	diagnosed
O	122	124	in
B-Characteristic	125	134	adulthood
O	135	138	and
O	139	141	to
O	142	150	describe
O	151	154	the
O	155	170	characteristics
O	171	173	of
O	174	182	patients
O	183	186	who
O	187	194	develop
O	195	197	it
O	197	198	.

O	199	212	Retrospective
O	213	226	observational
O	227	231	case
O	232	238	series
O	238	239	.

O	240	248	Thirteen
B-Anatomy	249	253	eyes
O	254	256	of
O	257	259	13
O	260	268	patients
O	269	273	with
B-Disease	274	279	Coats
I-Disease	279	280	'
I-Disease	281	288	disease
O	289	298	diagnosed
B-Characteristic	299	304	after
I-Characteristic	305	308	age
I-Characteristic	309	311	35
I-Characteristic	312	317	years
O	317	318	.

O	319	322	All
O	323	331	patients
O	332	340	examined
O	341	343	in
O	344	347	the
O	348	355	authors
O	355	356	'
O	357	365	referral
O	366	375	practices
O	376	379	for
B-Disease	380	385	Coats
I-Disease	385	386	'
I-Disease	387	394	disease
O	395	404	diagnosed
B-Characteristic	405	410	after
I-Characteristic	411	414	the
I-Characteristic	415	418	age
I-Characteristic	419	421	of
I-Characteristic	422	424	35
I-Characteristic	425	430	years
O	431	435	were
O	436	446	identified
O	446	447	.

O	448	456	Patients
O	457	461	with
O	462	463	a
O	464	471	history
O	472	474	of
B-Characteristic	475	484	radiation
I-Characteristic	485	493	exposure
O	493	494	,
B-Characteristic	495	506	intraocular
I-Characteristic	507	519	inflammation
O	519	520	,
B-Characteristic	521	528	retinal
I-Characteristic	529	537	vascular
I-Characteristic	538	547	occlusion
O	547	548	,
O	549	551	or
B-Characteristic	552	557	Coats
I-Characteristic	557	558	'
I-Characteristic	559	567	response
O	568	572	were
O	573	581	excluded
O	581	582	.

O	583	584	A
O	585	591	review
O	592	594	of
O	595	600	their
O	601	611	historical
O	611	612	,
O	613	621	clinical
O	621	622	,
O	623	626	and
B-Diagnostic_tool	627	638	fluorescein
I-Diagnostic_tool	639	651	angiographic
O	652	660	features
O	661	664	and
B-Characteristic	665	677	demographics
O	678	681	was
O	682	691	performed
O	691	692	.

O	693	698	There
O	699	703	were
O	704	706	13
O	707	715	patients
O	716	720	with
O	721	722	a
O	723	727	mean
B-Characteristic	728	731	age
I-Characteristic	732	734	at
I-Characteristic	735	744	diagnosis
I-Characteristic	745	747	of
I-Characteristic	748	750	50
I-Characteristic	751	756	years
I-Characteristic	757	758	(
I-Characteristic	758	763	range
I-Characteristic	763	764	,
I-Characteristic	765	767	36
I-Characteristic	767	768	-
I-Characteristic	768	770	79
I-Characteristic	770	771	)
O	772	775	and
O	776	777	a
O	778	782	mean
B-Characteristic	783	789	follow
I-Characteristic	789	790	-
I-Characteristic	790	792	up
I-Characteristic	793	795	of
I-Characteristic	796	797	5
I-Characteristic	797	798	.
I-Characteristic	798	799	8
I-Characteristic	800	805	years
I-Characteristic	806	807	(
I-Characteristic	807	812	range
I-Characteristic	812	813	,
I-Characteristic	814	815	0
I-Characteristic	815	816	-
I-Characteristic	816	818	17
I-Characteristic	818	819	)
O	819	820	.

O	821	826	These
O	827	835	patients
O	836	846	manifested
O	847	851	many
O	852	860	findings
O	861	868	typical
O	869	871	of
B-Disease	872	877	Coats
I-Disease	877	878	'
I-Disease	879	886	disease
O	886	887	,
O	888	897	including
O	898	901	the
O	902	912	unilateral
O	913	919	nature
O	920	922	of
O	923	926	the
O	927	934	disease
O	935	936	(
O	936	938	13
O	938	939	/
O	939	941	13
O	942	950	patients
O	950	951	)
O	951	952	,
B-Characteristic	953	957	male
O	958	970	predominance
O	971	972	(
O	972	974	12
O	974	975	/
O	975	977	13
O	977	978	)
O	978	979	,
B-Symptom	980	988	vascular
I-Symptom	989	1003	telangiectasis
O	1003	1004	,
B-Symptom	1005	1010	lipid
I-Symptom	1011	1020	exudation
O	1020	1021	,
B-Symptom	1022	1029	macular
I-Symptom	1030	1035	edema
O	1035	1036	,
O	1037	1040	and
B-Symptom	1041	1046	areas
I-Symptom	1047	1049	of
I-Symptom	1050	1059	capillary
I-Symptom	1060	1072	nonperfusion
I-Symptom	1073	1077	with
I-Symptom	1078	1086	adjacent
I-Symptom	1087	1091	webs
I-Symptom	1092	1094	of
I-Symptom	1095	1107	filigreelike
I-Symptom	1108	1119	capillaries
O	1119	1120	.

O	1121	1128	Disease
O	1129	1132	was
O	1133	1140	limited
O	1141	1143	to
O	1145	1146	<
O	1148	1150	or
O	1151	1152	=
O	1152	1153	6
O	1154	1159	clock
O	1160	1165	hours
O	1166	1168	in
O	1169	1171	10
O	1172	1174	of
O	1175	1177	13
O	1178	1186	patients
O	1187	1188	(
O	1188	1190	76
O	1190	1191	.
O	1191	1192	9
O	1192	1193	%
O	1193	1194	)
O	1194	1195	,
O	1196	1199	did
O	1200	1203	not
O	1204	1213	generally
O	1214	1221	involve
O	1222	1225	the
B-Anatomy	1226	1233	retinal
I-Anatomy	1234	1245	vasculature
I-Anatomy	1246	1254	anterior
I-Anatomy	1255	1257	to
I-Anatomy	1258	1261	the
I-Anatomy	1262	1269	equator
O	1269	1270	,
O	1271	1274	and
O	1275	1281	showed
O	1282	1289	limited
O	1290	1299	potential
O	1300	1302	to
O	1303	1309	expand
O	1310	1316	during
O	1317	1320	the
O	1321	1327	follow
O	1327	1328	-
O	1328	1330	up
O	1331	1337	period
O	1337	1338	.

O	1339	1340	A
B-Symptom	1341	1350	localized
I-Symptom	1351	1361	hemorrhage
O	1362	1365	was
O	1366	1371	noted
O	1372	1374	in
O	1375	1377	10
O	1378	1380	of
O	1381	1383	13
O	1384	1392	patients
O	1393	1394	(
O	1394	1396	76
O	1396	1397	.
O	1397	1398	9
O	1398	1399	%
O	1399	1400	)
O	1400	1401	,
O	1402	1408	almost
O	1409	1415	always
O	1416	1420	near
B-Symptom	1421	1427	larger
I-Symptom	1428	1438	aneurysmal
I-Symptom	1439	1450	dilatations
O	1450	1451	.

B-Symptom	1452	1459	Limited
I-Symptom	1460	1469	exudative
I-Symptom	1470	1480	detachment
I-Symptom	1481	1483	of
I-Symptom	1484	1487	the
I-Symptom	1488	1494	retina
O	1495	1498	was
O	1499	1503	seen
O	1504	1506	in
O	1507	1508	4
B-Anatomy	1509	1513	eyes
O	1513	1514	,
O	1515	1516	3
O	1517	1519	of
O	1520	1525	which
O	1526	1535	responded
O	1536	1538	to
O	1539	1548	localized
O	1549	1554	laser
O	1555	1571	photocoagulation
O	1571	1572	.

O	1573	1576	One
O	1577	1584	patient
O	1585	1588	had
B-Symptom	1589	1599	subretinal
I-Symptom	1600	1605	fluid
O	1606	1610	seen
O	1611	1613	on
B-Diagnostic_tool	1614	1620	ocular
I-Diagnostic_tool	1621	1630	coherence
I-Diagnostic_tool	1631	1641	tomography
O	1642	1646	that
O	1647	1650	did
O	1651	1654	not
O	1655	1662	require
O	1663	1672	treatment
O	1672	1673	.

O	1674	1676	On
O	1677	1684	average
O	1684	1685	,
O	1686	1694	patients
O	1695	1699	lost
O	1700	1701	2
O	1701	1702	.
O	1702	1703	1
O	1704	1709	lines
O	1710	1712	of
B-Characteristic	1713	1719	visual
I-Characteristic	1720	1726	acuity
O	1727	1733	during
O	1734	1737	the
O	1738	1744	follow
O	1744	1745	-
O	1745	1747	up
O	1748	1754	period
O	1754	1755	;
O	1756	1757	6
O	1758	1766	patients
O	1767	1770	had
O	1771	1772	a
B-Symptom	1773	1780	decline
I-Symptom	1781	1783	in
I-Symptom	1784	1790	vision
O	1790	1791	,
O	1792	1793	2
O	1794	1802	patients
O	1803	1806	had
B-Symptom	1807	1815	improved
I-Symptom	1816	1822	vision
O	1822	1823	,
O	1824	1827	and
O	1828	1829	3
O	1830	1838	patients
O	1839	1842	had
B-Characteristic	1843	1849	stable
I-Characteristic	1850	1856	vision
O	1856	1857	.

O	1858	1860	No
O	1861	1868	patient
O	1869	1872	had
O	1873	1876	end
O	1876	1877	-
O	1877	1882	stage
O	1883	1891	findings
O	1892	1894	of
B-Disease	1895	1900	Coats
I-Disease	1900	1901	'
I-Disease	1902	1909	disease
O	1909	1910	,
O	1911	1915	such
O	1916	1918	as
B-Symptom	1919	1923	iris
I-Symptom	1924	1942	neovascularization
O	1943	1945	or
B-Symptom	1946	1951	total
I-Symptom	1952	1961	exudative
I-Symptom	1962	1972	detachment
O	1972	1973	.

B-Disease	1974	1979	Coats
I-Disease	1979	1980	'
I-Disease	1981	1988	disease
O	1989	1992	can
O	1993	1998	first
O	1999	2001	be
O	2002	2011	diagnosed
O	2012	2014	in
B-Characteristic	2015	2024	adulthood
O	2025	2029	with
B-Symptom	2030	2037	retinal
I-Symptom	2038	2046	vascular
I-Symptom	2047	2060	abnormalities
O	2061	2068	similar
O	2069	2071	to
O	2072	2077	those
O	2078	2082	seen
O	2083	2085	in
B-Characteristic	2086	2093	younger
I-Characteristic	2094	2102	patients
O	2102	2103	.

O	2104	2109	There
O	2110	2113	are
O	2114	2115	a
O	2116	2122	number
O	2123	2125	of
O	2126	2135	important
O	2136	2147	differences
O	2148	2150	in
O	2151	2158	disease
O	2159	2172	manifestation
O	2173	2175	in
B-Characteristic	2176	2182	adults
O	2182	2183	,
O	2184	2193	including
O	2194	2201	limited
O	2202	2206	area
O	2207	2209	of
O	2210	2221	involvement
O	2221	2222	,
O	2223	2229	slower
O	2230	2238	apparent
O	2239	2250	progression
O	2251	2253	of
O	2254	2261	disease
O	2261	2262	,
O	2263	2266	and
B-Symptom	2267	2277	hemorrhage
I-Symptom	2278	2282	near
I-Symptom	2283	2289	larger
I-Symptom	2290	2298	vascular
I-Symptom	2299	2310	dilatations
O	2310	2311	.
